NASDAQ:IINN Inspira Technologies Oxy B.H.N. (IINN) Stock Price, News & Analysis → Could this Tiny Biotech End Disease Forever? (From Behind the Markets) (Ad) Free IINN Stock Alerts $2.16 -0.05 (-2.26%) (As of 10:32 AM ET) Add Compare Share Share Today's Range$2.14▼$2.2050-Day Range$1.49▼$2.2152-Week Range$0.76▼$2.49Volume19,101 shsAverage Volume901,899 shsMarket Capitalization$27.26 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get Inspira Technologies Oxy B.H.N. alerts: Email Address Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him About Inspira Technologies Oxy B.H.N. Stock (NASDAQ:IINN)Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.Read More IINN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IINN Stock News HeadlinesMay 2, 2024 | prnewswire.comInspira™ Announces Start of Production of the INSPIRA™ ART100May 2, 2024 | americanbankingnews.comInspira Technologies Oxy B.H.N. (NASDAQ:IINN) Trading Up 3.2%May 8, 2024 | Behind the Markets (Ad)Fidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.April 25, 2024 | prnewswire.comInspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100April 16, 2024 | prnewswire.comInspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant ProceduresApril 16, 2024 | prnewswire.comInspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant ProceduresApril 10, 2024 | finance.yahoo.comInspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream InfectionsApril 10, 2024 | prnewswire.comInspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream InfectionsMay 8, 2024 | Behind the Markets (Ad)Fidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.April 3, 2024 | prnewswire.comInspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial WombApril 1, 2024 | msn.comInspira Technologies declines 9% on $1.65M direct fundingMarch 27, 2024 | finance.yahoo.comCompanies Like Inspira Technologies Oxy B.H.N (NASDAQ:IINN) Could Be Quite RiskyMarch 25, 2024 | prnewswire.comInspira™ Technologies Reports Full Year 2023 Financial ResultsMarch 12, 2024 | markets.businessinsider.comInspira: New Data Shows Superiority Of Orbiting Blood Oxygenation TechnologyMarch 12, 2024 | finance.yahoo.comInspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS IndicatorMarch 4, 2024 | prnewswire.comInspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within DaysFebruary 27, 2024 | finance.yahoo.comInspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution AgreementsFebruary 27, 2024 | finance.yahoo.comInspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major MilestoneFebruary 27, 2024 | prnewswire.comInspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major MilestoneFebruary 27, 2024 | prnewswire.comInspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution AgreementsFebruary 23, 2024 | benzinga.comInspira Technologies Oxy Stock (NASDAQ:IINN) Dividends: History, Yield and DatesFebruary 22, 2024 | finance.yahoo.comInspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologiesFebruary 22, 2024 | prnewswire.comInspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologiesFebruary 14, 2024 | finanznachrichten.deInspira Technologies: Inspira Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery SystemFebruary 14, 2024 | msn.comInspira stock soars 37% on US patent award for respiratory technologyFebruary 14, 2024 | finance.yahoo.comInspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery SystemFebruary 14, 2024 | prnewswire.comInspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery SystemSee More Headlines Receive IINN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inspira Technologies Oxy B.H.N. and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/08/2024Next Earnings (Estimated)6/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:IINN CUSIPN/A CIK1837493 Webinspira-technologies.com Phone972-4623-0333FaxN/AEmployees32Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-11,290,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-158.18% Return on Assets-108.21% Debt Debt-to-Equity Ratio0.10 Current Ratio2.61 Quick Ratio2.61 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.45 per share Price / Book4.91Miscellaneous Outstanding Shares12,620,000Free Float8,910,000Market Cap$27.89 million OptionableNot Optionable Beta2.13 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Dagi Shahar Ben-Noon (Age 48)Co-Founder, CEO & Director Comp: $290.31kMr. Joe Hayon (Age 50)Co-Founder, President & Director Comp: $292.85kMr. Avi Shabtai (Age 50)COO and VP of Research & Development Comp: $339.36kMeshira GreenbergAdministrative ManagerAdi ShmueliMarketing & Communications ManagerKey CompetitorsSpectral AINASDAQ:MDAILyra TherapeuticsNASDAQ:LYRANeuroOne Medical TechnologiesNASDAQ:NMTCFemasysNASDAQ:FEMYAkiliNASDAQ:AKLIView All CompetitorsInstitutional OwnershipArmistice Capital LLCBought 1,528,000 shares on 2/13/2024Ownership: 0.000%View All Institutional Transactions IINN Stock Analysis - Frequently Asked Questions How have IINN shares performed in 2024? Inspira Technologies Oxy B.H.N.'s stock was trading at $1.06 at the start of the year. Since then, IINN shares have increased by 103.8% and is now trading at $2.16. View the best growth stocks for 2024 here. Are investors shorting Inspira Technologies Oxy B.H.N.? Inspira Technologies Oxy B.H.N. saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 221,500 shares, a drop of 24.9% from the March 15th total of 295,100 shares. Based on an average daily volume of 1,110,000 shares, the short-interest ratio is currently 0.2 days. Currently, 1.4% of the company's shares are short sold. View Inspira Technologies Oxy B.H.N.'s Short Interest. When is Inspira Technologies Oxy B.H.N.'s next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, June 24th 2024. View our IINN earnings forecast. When did Inspira Technologies Oxy B.H.N. IPO? Inspira Technologies Oxy B.H.N. (IINN) raised $19 million in an initial public offering on Wednesday, July 14th 2021. The company issued 2,909,091 shares at a price of $5.50-$7.50 per share. How do I buy shares of Inspira Technologies Oxy B.H.N.? Shares of IINN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:IINN) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward PressAI “wealth window” is closing June 25thParadigm PressClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspira Technologies Oxy B.H.N. Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
